The Safety and Tolerability Profile of Vilazodone, A Novel Antidepressant for the Treatment of Major Depressive Disorder

OBJECTIVE: Vilazodone is a selective serotonin reuptake inhibitor and 5-HT(1A) receptor partial agonist approved for the treatment of major depressive disorder (MDD). This report summarizes the safety and tolerability of vilazodone 40 mg/day during short- and long-term treatment of adult MDD. METHOD...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Psychopharmacol Bull
Main Authors: Liebowitz, Michael, Croft, Harry A., Kajdasz, Daniel K., Whalen, Heidi, Gallipoli, Susan, Athanasiou, Maria, Reed, Carol R.
Formato: Artigo
Idioma:Inglês
Publicado em: MedWorks Media Global 2011
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5044546/
https://ncbi.nlm.nih.gov/pubmed/27738360
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados